Lexeo Therapeutics, Inc. (NASDAQ:LXEO) is one of the 11 Best New Penny Stocks to Buy Right Now. On July 7, Stifel reiterated its “Buy” rating for Lexeo Therapeutics, Inc.

While colleges across the nation are adapting their curricula to harness the power of generative AI, U.S. medical schools remain dangerously behind.

Johnson & Johnson (NYSE:JNJ) is one of the best trade‑war resistant stocks to buy now. On July 21, 2025, J&J submitted a New ...

In April, 2025, Demis Hassabis, the Nobel Prize-winning CEO of Google DeepMind, appeared on the US television show 60 Minutes and suggested that all diseases could be curable with the help of ...

From overlooked diagnostics and underused screening to AI potential and workforce gaps, these are the innovation challenges in oncology that cancer leaders told Becker’s they feel deserve more ...

Carlsbad, California–based Carlsmed designed the Aprevo devices to match the unique anatomical and alignment needs of each ...

AI was supposed to boost drug discovery, but progress has stalled. Learn why the hype hasn’t delivered and what needs to ...

Artificial intelligence is increasingly being used by insurers to approve or deny medical treatments. According to WETM, ...

Over the past decade, health insurance companies have increasingly embraced the use of artificial intelligence algorithms – ...

— Help teens recognize that AI companions are programmed to be agreeable and validating. Explain that’s not how real ...

Teenagers are increasingly turning to AI for advice, emotional support and decision-making, according to a new study.

Researchers at Johns Hopkins University have developed SRT-H, an AI that autonomously guided a da Vinci robot through complex ...